Biological pathophysiology of mood disorders special reference to the neurotransmitter receptors

Seishin Shinkeigaku Zasshi. 2004;106(8):1032-6.
No abstract available

Publication types

  • Review

MeSH terms

  • Amoxapine / pharmacology
  • Amoxapine / therapeutic use
  • Animals
  • Antidepressive Agents, Second-Generation / pharmacology
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Brain / metabolism
  • Humans
  • Ligands
  • Membrane Glycoproteins / metabolism
  • Membrane Glycoproteins / physiology*
  • Membrane Transport Proteins / metabolism
  • Membrane Transport Proteins / physiology*
  • Mood Disorders / drug therapy
  • Mood Disorders / etiology*
  • Mood Disorders / metabolism
  • Nerve Tissue Proteins / metabolism
  • Nerve Tissue Proteins / physiology*
  • Paroxetine / pharmacology
  • Paroxetine / therapeutic use
  • Receptor, Serotonin, 5-HT1A / metabolism
  • Receptor, Serotonin, 5-HT1A / physiology*
  • Receptors, Dopamine D1 / metabolism
  • Receptors, Dopamine D1 / physiology*
  • Receptors, Serotonin, 5-HT2 / metabolism
  • Receptors, Serotonin, 5-HT2 / physiology*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Serotonin Plasma Membrane Transport Proteins
  • Trazodone / pharmacology
  • Trazodone / therapeutic use

Substances

  • Antidepressive Agents, Second-Generation
  • Ligands
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Receptors, Dopamine D1
  • Receptors, Serotonin, 5-HT2
  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Uptake Inhibitors
  • Receptor, Serotonin, 5-HT1A
  • Paroxetine
  • Amoxapine
  • Trazodone